Abstract:Mitochondrial DNA (mtDNA) somatic mutations play important roles in the initiation and progression of cancer. Although next-generation sequencing (NGS) of paired tumor and control samples has become a common practice to identify tumor-specific mtDNA mutations, the unique nature of mtDNA and NGS-associated sequencing bias could cause false-positive/-negative somatic mutation calling. Additionally, there are clinical scenarios where matched control tissues are unavailable for comparison. Therefore, a novel approach for accurately identifying somatic mtDNA variants is greatly needed, particularly in the absence of matched controls. In this study, the ground truth mtDNA variants orthogonally validated by triple-paired tumor, adjacent nontumor, and blood samples were used to develop mitoSomatic, a random forest-based machine learning tool. We demonstrated that mitoSomatic achieved area under the curve (AUC) values over 0.99 for identifying somatic mtDNA variants without paired control in three tumor types. In addition, mitoSomatic was also applicable in nontumor tissues such as adjacent nontumor and blood samples, suggesting the flexibility of mitoSomatic's classification capability. Furthermore, analysis of triple-paired samples identified a small group of variants with uncertain somatic/germline origin, whereas application of mitoSomatic significantly facilitated the prediction of their possible source. Finally, a control-free evaluation of the public pan-cancer NGS dataset with mitoSomatic revealed a substantial number of variants that were probably misclassified by conventional tumor-control comparison, further emphasizing the usefulness of mitoSomatic in application. Taken together, our study demonstrates that mitoSomatic is valuable for accurately identifying somatic mtDNA variants in mtDNA NGS data without paired controls, applicable for both tumor and nontumor tissues.

Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing

Single-molecule, Quantitative Detection of Low-Abundance Somatic Mutations by High-Throughput Sequencing

Somatic Point Mutation Calling in Low Cellularity Tumors

A High-Fidelity Method for Genomic Sequencing of Single Somatic Cells Reveals a Very High Mutational Burden

Detecting Somatic Mutations Without Matched Normal Samples Using Long Reads

Detection of ultra-rare mutations by next-generation sequencing

Analyzing somatic mutations by single-cell whole-genome sequencing

A Novel Next-Generation Sequencing–Based Approach for Concurrent Detection of Mitochondrial DNA Copy Number and Mutation

A Novel Method for Detecting Mutation of Mitochondrial DNA in Tumor Cells by Next Generation Sequencing

An Analysis of the Sensitivity of Proteogenomic Mapping of Somatic Mutations and Novel Splicing Events in Cancer

Massively parallel single-cell mitochondrial DNA genotyping and chromatin profiling

Single molecule targeted sequencing for cancer gene mutation detection

Mitosomatic: a Tool for Accurate Identification of Mitochondrial DNA Somatic Mutations Without Paired Controls

Somatic mutation and selection at epidemiological scale

Detecting somatic point mutations in cancer genome sequencing data: a comparison of mutation callers

An innovative data analysis strategy for accurate next-generation sequencing detection of tumor mitochondrial DNA mutations

Comprehensive and realistic simulation of tumour genomic sequencing data

Whole genome DNA sequencing provides an atlas of somatic mutagenesis in healthy human cells and identifies a tumor-prone cell type

Application of Next-Generation Sequencing in the Detection of Low-Abundance Mutations.

Germline And Somatic Variant Identification Using Bgiseq-500 And Hiseq X Ten Whole Genome Sequencing

Comprehensive next-generation sequence analyses of the entire mitochondrial genome reveal new insights into the molecular diagnosis of mitochondrial DNA disorders